KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Exact Sciences (EXAS) over the last 17 years, with Q3 2025 value amounting to $190.0 million.

  • Exact Sciences' Free Cash Flow rose 6882.05% to $190.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $247.1 million, marking a year-over-year increase of 15103.17%. This contributed to the annual value of $74.5 million for FY2024, which is 13347.74% up from last year.
  • As of Q3 2025, Exact Sciences' Free Cash Flow stood at $190.0 million, which was up 6882.05% from $46.7 million recorded in Q2 2025.
  • In the past 5 years, Exact Sciences' Free Cash Flow registered a high of $190.0 million during Q3 2025, and its lowest value of -$207.4 million during Q1 2022.
  • In the last 5 years, Exact Sciences' Free Cash Flow had a median value of -$826000.0 in 2023 and averaged -$17.5 million.
  • As far as peak fluctuations go, Exact Sciences' Free Cash Flow tumbled by 181038.0% in 2022, and later soared by 1372723.97% in 2024.
  • Over the past 5 years, Exact Sciences' Free Cash Flow (Quarter) stood at -$84.0 million in 2021, then surged by 75.18% to -$20.8 million in 2022, then skyrocketed by 266.16% to $34.6 million in 2023, then crashed by 68.96% to $10.7 million in 2024, then surged by 1668.18% to $190.0 million in 2025.
  • Its Free Cash Flow was $190.0 million in Q3 2025, compared to $46.7 million in Q2 2025 and -$365000.0 in Q1 2025.